Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA)

CUSIP: 046513107

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
9,606,000
Total 13F shares
62,604,589
Share change
+1,634,383
Total reported value
$531,867,879
Put/Call ratio
44%
Price per share
$8.51
Number of holders
106
Value change
+$2,830,287
Number of buys
64
Number of sells
46

Security key

046513107

Report period

Q1 2020

Institutions

106

Top holders

10

Top shareholders of ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAUPOST GROUP LLC/MA
13F
Company
86%
8,308,900
$136,848,000 31 Dec 2019
13F
MAVERICK CAPITAL LTD
13F
Company
52%
4,958,431
$81,665,000 31 Dec 2019
13F
Redmile Group, LLC
13F
Company
48%
4,648,570
$76,562,000 31 Dec 2019
13F
BlackRock Finance, Inc.
13F
Company
48%
4,580,414
$75,438,000 31 Dec 2019
13F
VANGUARD GROUP INC
13F
Company
38%
3,681,701
$60,637,000 31 Dec 2019
13F
Camber Capital Management LP
13F
Company
31%
2,950,000
$48,587,000 31 Dec 2019
13F
BRIDGER MANAGEMENT, LLC
13F
Company
31%
2,932,865
$48,304,000 31 Dec 2019
13F
MORGAN STANLEY
13F
Company
31%
2,932,847
$48,304,000 31 Dec 2019
13F
JPMORGAN CHASE & CO
13F
Company
28%
2,669,931
$43,974,000 31 Dec 2019
13F
FEDERATED HERMES, INC.
13F
Company
24%
2,284,473
$37,625,000 31 Dec 2019
13F
STATE STREET CORP
13F
Company
23%
2,200,472
$36,242,000 31 Dec 2019
13F
CANADA PENSION PLAN INVESTMENT BOARD
13F
Company
19%
1,800,000
$29,646,000 31 Dec 2019
13F
Artal Group S.A.
13F
Company
18%
1,750,000
$28,823,000 31 Dec 2019
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
17%
1,621,365
$26,703,000 31 Dec 2019
13F
CARILLON TOWER ADVISERS, INC.
13F
Company
13%
1,220,241
$20,097,369 31 Dec 2019
13F
WASATCH ADVISORS LP
13F
Company
11%
1,101,103
$18,135,000 31 Dec 2019
13F
NORGES BANK
13F
Company
10%
1,003,746
$16,532,000 31 Dec 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
7.6%
733,447
$12,079,000 31 Dec 2019
13F
FMR LLC
13F
Company
7%
674,690
$11,112,000 31 Dec 2019
13F
NORTHERN TRUST CORP
13F
Company
7%
673,087
$11,086,000 31 Dec 2019
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
6.5%
626,144
$10,312,000 31 Dec 2019
13F
Alberta Investment Management Corp
13F
Company
5.6%
538,230
$8,865,000 31 Dec 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
4.4%
422,532
$6,959,000 31 Dec 2019
13F
Assenagon Asset Management S.A.
13F
Company
4.4%
421,218
$6,937,000 31 Dec 2019
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
3.5%
334,706
$5,513,000 31 Dec 2019
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
3.5%
331,911
$5,467,000 31 Dec 2019
13F
AMERIPRISE FINANCIAL INC
13F
Company
3.4%
331,236
$5,453,000 31 Dec 2019
13F
PINNACLE ASSOCIATES LTD
13F
Company
3.4%
324,020
$5,337,000 31 Dec 2019
13F
DEUTSCHE BANK AG\
13F
Company
3.2%
311,476
$5,129,000 31 Dec 2019
13F
Nuveen Asset Management, LLC
13F
Company
3%
292,570
$4,819,000 31 Dec 2019
13F
CITADEL ADVISORS LLC
13F
Company
2.7%
255,916
$4,215,000 31 Dec 2019
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
2.5%
240,631
$3,963,000 31 Dec 2019
13F
Bank of New York Mellon Corp
13F
Company
2.2%
211,796
$3,488,000 31 Dec 2019
13F
TWO SIGMA ADVISERS, LP
13F
Company
2.1%
200,900
$3,309,000 31 Dec 2019
13F
Coronation Fund Managers Ltd.
13F
Company
2.1%
198,166
$3,264,000 31 Dec 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.9%
183,372
$3,020,000 31 Dec 2019
13F
CITIGROUP INC
13F
Company
1.9%
182,024
$2,998,000 31 Dec 2019
13F
PACIFIC HEIGHTS ASSET MANAGEMENT LLC
13F
Company
1.8%
175,000
$2,882,000 31 Dec 2019
13F
PUBLIC SECTOR PENSION INVESTMENT BOARD
13F
Company
1.7%
159,474
$2,627,000 31 Dec 2019
13F
12 West Capital Management LP
13F
Company
1.7%
158,700
$2,614,000 31 Dec 2019
13F
AXA S.A.
13F
Company
1.4%
137,900
$2,271,000 31 Dec 2019
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
1.1%
106,619
$1,756,000 31 Dec 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
1.1%
102,704
$1,692,000 31 Dec 2019
13F
PDT Partners, LLC
13F
Company
1.1%
101,819
$1,677,000 31 Dec 2019
13F
Vident Investment Advisory, LLC
13F
Company
1%
97,273
$1,602,000 31 Dec 2019
13F
Swiss National Bank
13F
Company
0.96%
92,500
$1,523,000 31 Dec 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.96%
92,384
$1,521,000 31 Dec 2019
13F
Trellus Management Company, LLC
13F
Company
0.91%
87,873
$1,447,000 31 Dec 2019
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.88%
84,065
$1,385,000 31 Dec 2019
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.82%
78,639
$1,295,000 31 Dec 2019
13F

Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA) as of Q1 2020

As of 31 Mar 2020, Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA) was held by 106 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 62,604,589 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, Redmile Group, LLC, MAVERICK CAPITAL LTD, BlackRock Inc., VANGUARD GROUP INC, MORGAN STANLEY, FEDERATED HERMES, INC., JPMORGAN CHASE & CO, Artal Group S.A., and BRIDGER MANAGEMENT, LLC. This page lists 106 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders
112
Q1 2020 holders
106
Holder diff
-6
Investor Q4 2019 Shares Q1 2020 Shares Share Diff Share Chg % Q4 2019 Value $ Q1 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .